BlackRock Group’s Celgene Corp CELG Stock Holding History

BlackRock Group’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$854M	Buy	7,381,858 +570,689	+8%	+$63.6M	0.41%	50
2016 Q3	$712M	Buy	6,811,169 +172,828	+3%	+$18.7M	0.36%	54
2016 Q2	$655M	Sell	6,638,341 -901,757	-12%	-$93.3M	0.34%	56
2016 Q1	$755M	Buy	7,540,098 +3,023	+0%	+$311K	0.41%	49
2015 Q4	$903M	Buy	7,537,075 +81,481	+1%	+$9.43M	0.5%	42
2015 Q3	$806M	Buy	7,455,594 +217,996	+3%	+$27.1M	0.47%	47
2015 Q2	$838M	Sell	7,237,598 -51,988	-0.7%	-$5.94M	0.46%	47
2015 Q1	$840M	Sell	7,289,586 -171,290	-2%	-$20.5M	0.45%	48
2014 Q4	$835M	Buy	7,460,876 +371,332	+5%	+$39.2M	0.45%	46
2014 Q3	$672M	Sell	7,089,544 -58,082	-0.8%	-$5.24M	0.39%	52
2014 Q2	$614M	Buy	7,147,626 +160,982	+2%	+$12.2M	0.35%	62
2014 Q1	$488M	Buy	6,986,644 +58,060	+0.8%	+$4.6M	0.31%	67
2013 Q4	$585M	Sell	6,928,584 -694,952	-9%	-$55M	0.38%	55
2013 Q3	$588M	Buy	7,623,536 +620,448	+9%	+$43.5M	0.39%	52
2013 Q2	$410M	Buy	+7,003,088	New	+$421M	0.31%	63

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock Group's CELG Position: Q4 2016 in Review

BlackRock Group increased its Celgene Corp (CELG) stake by 8.4% in Q4 2016, buying an estimated $63.6M and bringing the position to 7,381,858 shares worth $854M. The position accounts for 0.41% of the portfolio, ranked #50.

BlackRock Group first reported a position in CELG in Q2 2013 and has held it in 15 quarters since. The position peaked at $903M in Q4 2015. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

BlackRock Group held 7,381,858 shares of Celgene Corp worth $854M as of Q4 2016.
BlackRock Group bought 570,689 Celgene Corp shares in Q4 2016, an estimated $63.6M.
Celgene Corp made up 0.41% of BlackRock Group's portfolio in Q4 2016, its #50 holding.
BlackRock Group first reported a position in Celgene Corp in Q2 2013 and has held it in 15 quarters since.
BlackRock Group's Celgene Corp position peaked at $903M in Q4 2015.
1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.